Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study

Pharmacoepidemiology and Drug Safety

Volumn 20, Issue 7, 2011, Pages 689-699

  Re, Vincent Lo ^a,b   Lim, Joseph K ^c,d   Goetz, Matthew Bidwell ^e,f   Tate, Janet ^c,d   Bathulapalli, Harini ^c,d   Klein, Marina B ^g   Rimland, David ^h,i   Rodriguez Barradas, Maria C ^j,k   Butt, Adeel A ^a,l   Gibert, Cynthia L ^m,n   Brown, Sheldon T ^o   Kidwai, Farah ^c,d   Brandt, Cynthia ^c,d   Dorey Stein, Zachariah ^a   Reddy, K Rajender ^p   Justice, Amy C ^c,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g ROYAL VICTORIA HOSPITAL   (Canada)

^h ATLANTA VA MEDICAL CENTER   (United States)

ⁱ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^k BAYLOR COLLEGE OF MEDICINE   (United States)

^l UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^m VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁿ GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^o MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^p UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

End stage liver disease; Epidemiologic methods; Hepatic decompensation; Outcomes; Validation studies

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; AMMONIA; BILIRUBIN; HEPATITIS B SURFACE ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS RNA;

ABNORMAL LABORATORY RESULT; ACUTE HEPATITIS; ADULT; ALBUMIN BLOOD LEVEL; ALCOHOL LIVER CIRRHOSIS; ALGORITHM; ARTICLE; ASCITES; BACTERIAL PERITONITIS; BILIARY CIRRHOSIS; BILIRUBIN BLOOD LEVEL; CHRONIC LIVER DISEASE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DECOMPENSATED LIVER CIRRHOSIS; DIAGNOSTIC TEST ACCURACY STUDY; END STAGE LIVER DISEASE; ENDOSCOPY; ESOPHAGUS HEMORRHAGE; ESOPHAGUS VARICES; FEMALE; GASTRITIS; HEPATIC COMA; HEPATIC ENCEPHALOPATHY; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS DELTA VIRUS; HEPATORENAL SYNDROME; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INTERNATIONAL CLASSIFICATION OF DISEASES; INTERNATIONAL NORMALIZED RATIO; JAUNDICE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER FIBROSIS; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT; PARACENTESIS; PEPTIC ULCER; PERITONEAL FLUID; PORTAL HYPERTENSION; PREDICTIVE VALUE; PRIORITY JOURNAL; TREATMENT OUTCOME; ULTRASOUND; VALIDITY; VETERAN;

ADULT; ALGORITHMS; CHRONIC DISEASE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; LIVER CIRRHOSIS; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; UNITED STATES; VETERANS;

EID: 79959740392     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2148     Document Type: Article

References (35)

1. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Multivirc Group. Hepatology 1999; 30(4): 1054-1058.
2. Di Martino V, Rufat P, Boyer N, et al. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology 2001; 34(6): 1193-1199.
3. Fuster D, Planas R, Muga R, et al. Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapy. AIDS Res Hum Retroviruses 2004; 20(12): 1293-1297.
4. Garcia-Samaniego J, Soriano V, Castilla J, et al. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. Hepatitis/HIV Span Study Group. Am J Gastroenterol 1997; 92(7): 1130-1134.
5. Pol S, Lamorthe B, Thi NT, et al. Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. J Hepatol 1998; 28(6): 945-950.
6. Romeo R, Rumi MG, Donato MF, et al. Hepatitis C is more severe in drug users with human immunodeficiency virus infection. J Viral Hepat 2000; 7(4): 297-301.
7. Soto B, Sanchez-Quijano A, Rodrigo L, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997; 26(1): 1-5.
8. Fultz SL, Justice AC, Butt AA, Rabeneck L, Weissman S, Rodriguez-Barradas M. Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with human immunodeficiency virus infection. Clin Infect Dis 2003; 36(8): 1039-1046.
9. Justice AC, Dombrowski E, Conigliaro J, et al. Veterans Aging Cohort Study (VACS): overview and description. Med Care 2006; 44(8 Suppl 2): S13-S24.
10. Lamoreaux J. The organizational structure for medical information management in the Department of Veterans Affairs. An overview of major health care databases. Med Care 1996; 34(3 Suppl): MS31-MS44.
11. D'Amico G, Morabito A, Pagliaro L, Marubini E. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986; 31(5): 468-475.
12. Gines P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987; 7(1): 122-128.
13. Colombo M, de Franchis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991; 325(10): 675-680.
14. Tradati F, Colombo M, Mannucci PM, et al. A prospective multicenter study of hepatocellular carcinoma in italian hemophiliacs with chronic hepatitis C. The Study Group of the Association of Italian Hemophilia Centers. Blood 1998; 91(4): 1173-1177.
15. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan. Lancet 1981; 2(8256): 1129-1133.
16. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med 1998; 158(16): 1789-1795.
17. Gordon AJ, Maisto SA, McNeil M, et al. Three questions can detect hazardous drinkers. J Fam Pract 2001; 50(4): 313-320.
18. Bagchi A, Sambamoorthi U, McSpiritt E, Yanos P, Walkup J, Crystal S. Use of antipsychotic medications among HIV-infected individuals with schizophrenia. Schizophr Res 2004; 71(2-3): 435-444.
19. Lurie N, Popkin M, Dysken M, Moscovice I, Finch M. Accuracy of diagnoses of schizophrenia in Medicaid claims. Hosp Community Psychiatry 1992; 43(1): 69-71.
20. Walkup J, Sambamoorthi U, Crystal S. Incidence and consistency of antiretroviral use among HIV-infected medicaid beneficiaries with schizophrenia. J Clin Psychiatry 2001; 62(3): 174-178.
21. Fultz SL, Skanderson M, Mole LA, et al. Development and verification of a "virtual" cohort using the National VA Health Information System. Med Care 2006; 44(8 Suppl 2): S25-S30.
22. Walkup JT, Wei W, Sambamoorthi U, Crystal S. Sensitivity of an AIDS case-finding algorithm: who are we missing? Med Care 2004; 42(8): 756-763.
23. Fleming KM, Aithal GP, Card TR, West J. The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study. Aliment Pharmacol Ther 2010; 32(11-12): 1343-1350.
24. Giordano TP, Kramer JR, Souchek J, Richardson P, El-Serag HB. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Arch Intern Med 2004; 164(21): 2349-2354.
25. Weber R, Sabin CA, Friis-Moller N, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 2006; 166(15): 1632-1641.
26. Sulkowski MS, Mehta SH, Torbenson MS, et al. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults. AIDS 2007; 21(16): 2209-2216.
27. Balasubramanian S, Kowdley KV. Effect of alcohol on viral hepatitis and other forms of liver dysfunction. Clin Liver Dis 2005; 9(1): 83-101.
28. Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. Hepatology 2009; 49(6): 2087-2107.
29. Hoefs JC, Canawati HN, Sapico FL, Hopkins RR, Weiner J, Montgomerie JZ. Spontaneous bacterial peritonitis. Hepatology 1982; 2(4): 399-407.
30. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46(3): 922-938.
31. Grace ND, Groszmann RJ, Garcia-Tsao G, et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998; 28(3): 868-880.
32. Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med 1997; 337(7): 473-479.
33. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42(5): 1208-1236.
34. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35(3): 421-430.
35. Lockwood AH. Blood ammonia levels and hepatic encephalopathy. Metab Brain Dis 2004; 19(3-4): 345-349.